These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28801327)

  • 41. Arguments against the use of inhaled insulin.
    Hirsch IB
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S111-4. PubMed ID: 17563299
    [No Abstract]   [Full Text] [Related]  

  • 42. Improvement of Insulin Injection Technique: Examination of Current Issues and Recommendations.
    Spollett G; Edelman SV; Mehner P; Walter C; Penfornis A
    Diabetes Educ; 2016 Aug; 42(4):379-94. PubMed ID: 27216036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of diabetic ketoacidosis with subcutaneous insulin lispro.
    Czupryniak L; Saryusz-Wolska M; Pawlowski M; Loba J
    Am J Med; 2005 Jan; 118(1):96; author reply 96-7. PubMed ID: 15639220
    [No Abstract]   [Full Text] [Related]  

  • 44. Eating disorders and diabetes mellitus.
    Nicolau J; Masmiquel L
    Endocrinol Nutr; 2015; 62(7):297-9. PubMed ID: 26232260
    [No Abstract]   [Full Text] [Related]  

  • 45. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New modes of insulin administration: do they have a role in clinical diabetes?
    Rizza RA
    Ann Intern Med; 1986 Jul; 105(1):126-9. PubMed ID: 3087254
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients.
    Razavi Z; Maher S; Fredmal J
    Endocrine; 2018 Aug; 61(2):267-274. PubMed ID: 29797212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New technologies and old challenges in type 1 diabetes.
    Rodriguez H
    Diabetes Technol Ther; 2012 Dec; 14(12):1082-3. PubMed ID: 23216337
    [No Abstract]   [Full Text] [Related]  

  • 49. The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern.
    Currie CJ; Johnson JA
    Diabetes Obes Metab; 2012 Jan; 14(1):1-4. PubMed ID: 21736688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetic ketoacidosis and compliance.
    Hjort U; Christensen JH
    Lancet; 1998 Feb; 351(9103):674-5. PubMed ID: 9500357
    [No Abstract]   [Full Text] [Related]  

  • 51. Cerebral edema in a child with diabetic ketoacidosis before initial treatment.
    Takaya J; Ohashi R; Harada Y; Yamato F; Higashino H; Kobayashi Y; Kaneko K
    Pediatr Int; 2007 Jun; 49(3):395-6. PubMed ID: 17532843
    [No Abstract]   [Full Text] [Related]  

  • 52. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
    Burke KR; Schumacher CA; Harpe SE
    Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin pump-associated adverse events are common, but not associated with glycemic control, socio-economic status, or pump/infusion set type.
    Ross P; Gray AR; Milburn J; Kumarasamy IM; Wu F; Farrand S; Armishaw J; Wiltshire E; Rayns J; Tomlinson P; Wheeler BJ
    Acta Diabetol; 2016 Dec; 53(6):991-998. PubMed ID: 27585938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factitious self-manipulation of the external insulin pump in adolescents with Type 1 diabetes.
    Moreau F; Spizzo H; Bursztejn C; Berthoux V; Agin A; Pinget M; Pasquali JL; Kessler L
    Diabet Med; 2011 May; 28(5):623-4. PubMed ID: 21303404
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhaled insulin in type 1 diabetes.
    Chan NN; Baldeweg S; Tan TM; Hurel SI
    Lancet; 2001 Jun; 357(9272):1979. PubMed ID: 11729842
    [No Abstract]   [Full Text] [Related]  

  • 56. [Current insulin therapy--avoidable errors].
    Mehnert H
    Fortschr Med; 1998 Nov; 116(31):28-30, 32-3. PubMed ID: 9864893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A diabetic ketoacidosis in a context of hyperglycemia addiction.
    Rousseau G; Palmiere C; Dupont V; Verschoore M; Savary C; Jousset N; Rougé-Maillart C
    Int J Legal Med; 2018 May; 132(3):787-790. PubMed ID: 29034415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Syndrome of chronic overdose of insulin and hypoglycemic sulfanilamide drugs].
    Arzumetova DS; Saburenko MB; Shagazatova BKh; Zabikhodzhaeva GZ
    Klin Med (Mosk); 1989 Apr; 67(4):99-101. PubMed ID: 2666739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Minimizing the risk of developing cerebral edema during therapy for diabetic ketoacidosis.
    Carlotti AP; Bohn D; Kamel KS; Halperin ML
    Crit Care Med; 2007 May; 35(5):1450; author reply 1450-1. PubMed ID: 17446767
    [No Abstract]   [Full Text] [Related]  

  • 60. Ventricular bigeminy and trigeminy caused by hypophosphataemia during diabetic ketoacidosis treatment: a case report.
    Miszczuk K; Mroczek-Wacinska J; Piekarski R; Wysocka-Lukasik B; Jawniak R; Ben-Skowronek I
    Ital J Pediatr; 2019 Apr; 45(1):42. PubMed ID: 30940174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.